secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0000950170-24-061872
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics stockholders re-elect two Class III directors; ratify KPMG as auditor
--------------------------------------------------------------------------------

- Andrew Cheng re-elected with 27.4M votes for, 13.0M withheld; Scott Morrison with 31.6M for, 8.8M withheld.
- Broker non-votes were 1,020,833 for both director elections.
- KPMG ratified as independent auditor for FY2024: 41.4M for, 1,832 against, 7,116 abstain.
- Meeting held May 15, 2024; 54,451,375 Class A shares outstanding as of record date March 18.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000095017024061872/0000950170-24-061872-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000095017024061872/vera-20240515.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-061872

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer